Dr. F. Köhler Chemie GmbH
Giessen
What changed
Study registered, no phase assigned: AI-Guided Relaxation for Hemodialysis Anxiety
2mo agoTrial registeredMay 12, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 74 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Phase II
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Trial
NA registered
Mar 29, 2026Renal Insufficiency, Chronic, Anxiety, Relaxation Therapy, Maintenance Hemodialysis, Stress, Psychological · RECRUITING · sponsor: Alexandria University · AI-Guided Relaxation for Hemodialysis Anxiety
ClinicalTrials.gov · NCT07522944 (opens the source filing in a new tab)
- Trial
PHASE2 registered
Dec 5, 2024Congenital Heart Malformations · SUSPENDED · sponsor: Dr. F. Köhler Chemie GmbH · Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children
ClinicalTrials.gov · NCT07381530 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources